{"filing":{"accession":"0001437749-26-028651","url":"/filing/0001437749-26-028651","form_type":"4","issuer_cik":"0001710340","issuer_name":"Eton Pharmaceuticals, Inc.","issuer_name_source":null,"issuer_ticker":"ETON","issuer_url":"/issuer/0001710340","period_of_report":"2026-08-19","filed_date":"2026-08-20","acceptance_dt":"2026-08-20T18:26:19+00:00","acceptance_label":"2026-08-20 18:26 UTC","ingested_at":"2026-08-21T05:23:33.898496+00:00","ingested_label":"2026-08-21 05:23 UTC","schema_version":null,"source":"Layline","parse_status":"parsed","parse_ok":true,"edgar_url":"https://www.sec.gov/Archives/edgar/data/1710340/0001437749-26-028651-index.htm","day_url":"/filings/2026-08-20"},"owners":[{"owner_cik":"0001669976","owner_name":"BRYNJELSEN SEAN","url":"/insider/0001669976","anchor":"owner-0001669976","role":"Director, Officer (President & CEO)","officer_title":"President & CEO","is_director":true,"is_officer":true,"is_ten_percent":false,"is_other":false,"filing_anchor":"/filing/0001437749-26-028651#owner-0001669976"}],"line_owners":[{"owner_name":"BRYNJELSEN SEAN","role":"Director, Officer (President & CEO)"}],"transactions":[{"id":9299209,"accession":"0001437749-26-028651","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-26-028651","line_url":"/filing/0001437749-26-028651#line-1","is_derivative":false,"issuer_cik":"0001710340","issuer_name":"Eton Pharmaceuticals, Inc.","issuer_ticker":"ETON","issuer_name_source":null,"issuer_url":"/issuer/0001710340","owner_cik":"0001669976","owner_name":"BRYNJELSEN SEAN","owner_display_name":"BRYNJELSEN SEAN","owner_url":"/insider/0001669976","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":8978.0,"shares_display":"8,978","price_per_share":62.65,"price_display":"62.65","price_state":"stated","total_value":562471.7,"total_display":"562,471.70","total_whole":"562,472","shares_owned_after":1052216.0,"shares_owned_after_display":"1,052,216","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-19","filed_date":"2026-08-20","scope":"global","indirect_nature":null,"deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9299210,"accession":"0001437749-26-028651","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001437749-26-028651","line_url":"/filing/0001437749-26-028651#line-2","is_derivative":false,"issuer_cik":"0001710340","issuer_name":"Eton Pharmaceuticals, Inc.","issuer_ticker":"ETON","issuer_name_source":null,"issuer_url":"/issuer/0001710340","owner_cik":"0001669976","owner_name":"BRYNJELSEN SEAN","owner_display_name":"BRYNJELSEN SEAN","owner_url":"/insider/0001669976","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":47307.0,"shares_display":"47,307","price_per_share":60.17,"price_display":"60.17","price_state":"stated","total_value":2846462.19,"total_display":"2,846,462.19","total_whole":"2,846,462","shares_owned_after":1004909.0,"shares_owned_after_display":"1,004,909","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-20","filed_date":"2026-08-20","scope":"global","indirect_nature":null,"deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9299211,"accession":"0001437749-26-028651","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001437749-26-028651","line_url":"/filing/0001437749-26-028651#line-3","is_derivative":false,"issuer_cik":"0001710340","issuer_name":"Eton Pharmaceuticals, Inc.","issuer_ticker":"ETON","issuer_name_source":null,"issuer_url":"/issuer/0001710340","owner_cik":"0001669976","owner_name":"BRYNJELSEN SEAN","owner_display_name":"BRYNJELSEN SEAN","owner_url":"/insider/0001669976","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":36373.0,"shares_display":"36,373","price_per_share":61.11,"price_display":"61.11","price_state":"stated","total_value":2222754.03,"total_display":"2,222,754.03","total_whole":"2,222,754","shares_owned_after":968536.0,"shares_owned_after_display":"968,536","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-20","filed_date":"2026-08-20","scope":"global","indirect_nature":null,"deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null},{"id":9299212,"accession":"0001437749-26-028651","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001437749-26-028651","line_url":"/filing/0001437749-26-028651#line-4","is_derivative":false,"issuer_cik":"0001710340","issuer_name":"Eton Pharmaceuticals, Inc.","issuer_ticker":"ETON","issuer_name_source":null,"issuer_url":"/issuer/0001710340","owner_cik":"0001669976","owner_name":"BRYNJELSEN SEAN","owner_display_name":"BRYNJELSEN SEAN","owner_url":"/insider/0001669976","role":"Director, Officer (President & CEO)","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"President & CEO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7342.0,"shares_display":"7,342","price_per_share":62.12,"price_display":"62.12","price_state":"stated","total_value":456085.04,"total_display":"456,085.04","total_whole":"456,085","shares_owned_after":961194.0,"shares_owned_after_display":"961,194","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-08-20","filed_date":"2026-08-20","scope":"global","indirect_nature":null,"deemed_execution_date":null,"conversion_or_exercise_price":null,"exercise_date":null,"expiration_date":null,"underlying_security_title":null,"underlying_shares":null,"equity_swap_involved":null,"footnote_ids":null}],"n_transactions":4,"line_constants":{"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true},"provenance":{"source_pass":"Layline","parse_status":"parsed","schema_version":null,"retrieved_at":"2026-08-21T05:23:33.898496+00:00","retrieved_label":"2026-08-21 05:23 UTC","primary_document":"https://www.sec.gov/Archives/edgar/data/1710340/0001437749-26-028651-index.htm","accepted_at":"2026-08-20T18:26:19+00:00","accepted_label":"2026-08-20 18:26 UTC"},"related":[],"related_rule":"Other filings held for the same issuer and the same period of report. This is a heuristic match, not an authoritative amendment link: the store holds no 4/A-to-original relation and the catalog does not invent one.","canonical_url":"https://ebomi.com/filing/0001437749-26-028651","retrieved_at":"2026-08-27T22:21:50+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-26","last_ingest":"2026-08-27T05:24:39.644631+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}